Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

261 results
Display

Performance Evaluation of the QXDx BCR-ABL %IS Droplet Digital PCR Assay

Chung HJ, Hur M, Yoon S, Hwang K, Lim HS, Kim H, Moon HW, Yun YM

Accurate detection of BCR-ABL fusion transcripts at and below molecular response (MR) 4 (0.01% International Scale [IS]) is required for disease monitoring in patients with chronic myeloid leukemia (CML). We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
First Case of Transformation of Immunoglobulin Heavy Chain Variable-Mutated Chronic Lymphocytic Leukemia Into Chronic Myeloid Leukemia

Zhang X, Guo X

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Depigmentation in a Patient with Chronic Myeloid Leukemia during Chemotherapy with Dasatinib

Choi YW, Na N, Park J

  • KMID: 2451599
  • Korean J Dermatol.
  • 2019 Jun;57(5):292-293.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
First case report of latent tuberculosis reactivation complicating treatment with nilotinib in chronic myeloid leukemia

Kim DJ, Jeong S, Kong SG, Lee HS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Isolated monocytosis was the flag preceding abnormalities in other parameters of complete blood counts in chronic myeloid leukemia with e1a2 (minor, P190) BCR-ABL1 chimeric transcripts

Yun JW, Yoon J, Kim JW, Kim SH, Jung CW, Kim HJ

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm with the molecular hallmark of BCR-ABL1 chimeric transcripts from t(9;22)(q24;q22). In more than 95% of CML, the fusion occurs in the major...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib

Yi JH, Kim HR

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
ABCB1 and BMI1 mRNA expression in patients with chronic myeloid leukemia: impact on imatinib efficacy

Bedewy AM, Elmaghraby SM, Kandil NS

BACKGROUND: ATP-binding cassette transporters are important in the mechanism of multidrug resistance. ABCB1 displays a high affinity for imatinib. BMI1 is a polycomb group protein thought to be overexpressed in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Promyelocytic Leukemoid Reaction: Unusual Findings in a Patient with Sepsis

Kim YK

Neutrophilic leukemoid reaction may occur in many situations, including hemolysis, malignancy, infection, and exposure to certain toxins. It usually shows morphological overlap with chronic myeloid leukemia in which promyelocytes are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Anti-growth Effects of Imatinib and GNF5 via Regulation of Skp2 in Human Hepatocellular Carcinoma Cells

Kim SH, Kim MO, Kim KR

BACKGROUND: Human hepatocellular carcinoma (HCC) is a common liver tumor and the main cause of cancer-related death. Tyrosine kinase inhibitors, such as imatinib and GNF5 which were developed to treat...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Surgery for Pulmonary Fungal Infections Complicating Hematological Malignancies

Yamamichi , Horio H, Asakawa A, Okui M, Harada M

BACKGROUND: The complication rate of fungal disease is higher among patients with hematological malignancies. We investigated the clinicobacteriological outcomes of resected pulmonary fungal infections complicating hematological malignancies. METHODS: Between 2001 and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Emergence of chronic myeloid leukemia following autologous stem cell transplantation in a young woman with multiple myeloma

Barrett A, Glavey S, Sargent J, Thornton P, Murphy P, Quinn J

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multifocal large aggregates of pseudo-Gaucher cells in chronic myeloid leukemia

Sharma P, Kumar N, Varma N

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dasatinib (Sprycel®)-Associated Acneiform Eruption Improved by Dose Reduction due to Pleural Effusion in a Patient with Chronic Myeloid Leukemia

Lim JH, Woo Y, Kim M, Park HJ

  • KMID: 2436860
  • Korean J Dermatol.
  • 2018 Aug;56(7):472-474.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Granulocytic dysplasia: an indicator of clonal evolution in patients with chronic myeloid leukemia

Rajpal S, Nampoothiri RV, Sreedharanunni S, Parihar M, Malhotra P, Varma N

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Peripheral neuropathy associated with imatinib therapy for chronic myeloid leukemia

Kavanagh S, Bril V, Lipton JH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The first concurrent diagnosis of acute symptomatic Babesiosis and chronic myeloid leukemia in a healthy young adult

Xie Y, Visconte V, Duan L, Rogers HJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The incidence of atypical patterns of BCR-ABL1 rearrangement and molecular-cytogenetic response to tyrosine kinase inhibitor therapy in newly diagnosed cases with chronic myeloid leukemia (CML)

Švabek ZT, Josipović M, Horvat I, Zadro R, Davidović-Mrsić S

BACKGROUND: To analyze the frequency of atypical fluorescence in situ hybridization signal patterns and estimate the complete cytogenetic response (CCyR) and major molecular response (MMR) during 12 months of tyrosine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review

Choi JK, Cho SY, Choi SM, Kim GH, Lee SE, Lee S, Kim DW, Lee DG

Dasatinib, a tyrosine kinase inhibitor, is widely used for patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Although the drug has a potent immunosuppressive effect, infectious complications...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Successfully Treated Severe Heart Failure due to Cyclophosphamide Induced Cardiomyopathy

Park JM, Hahn SM, Han JW, Lyu CJ

Cyclophosphamide-induced cardiotoxicity is an uncommon complication especially in patients who have never undergone mediastinal irradiation or cardiotoxic chemotherapy and do not have underlying cardiac diseases. Here, we describe the case...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Additional cytogenetic aberrations in chronic myeloid leukemia: a single-center experience in the Middle East

Safaei A, Monabati A, Safavi M, Atashabparvar A, Hosseini M

BACKGROUND: Additional cytogenetic aberrations are associated with disease progression in chronic myeloid leukemia (CML). This study was conducted to determine the type and frequency of these aberrations and their relationship...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr